Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzhenghuayu plus entecavir for chronic hepatitis B with hepatic fibrosis
ChiCTR-TRC-11001377Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic Hepatitis B (CHB) and hepatic fibrosis comparing entecavir + Fuzhenghuayu with entecavir + placebo (2 arms). Primary endpoint: Liver function normalization rate. Started Mar 2011; status: completed.
02
Drugs
fuzheng huayuentecavir
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001377.